10 reasons to attend

 

1. Commercial focus – with over 50% of the attendance coming from pharma and biotech executives , this is the most important and commercially focused orphan drugs conference globally. Aside from strategic programs focusing on clinical development and regulatory topics, the conference has dedicated commercialization and global market access tracks tackling key challenges in patient access, international markets, marketing and pricing & reimbursement.

2. Program Comprehensiveness – WODC’s agenda breadth covers all aspects of rare disease research and orphan drug development, from early stage orphan drug R&D to commercialization, pricing & reimbursement and market access

3.  Public Authorities representation – presence of US and International authorities from multiple Payers, Government/Ministries of Health, and Regulators, including the FDA and EMA

4. Funding and Partnerships for biotechs entering the orphan drug market – through the Pitch & Partner program, the WODC provides a platform for smaller biotechs looking for funding and partnerships, as well as one for investors, pharma R&D and grant agencies to stay abreast of innovation among biotechs with recent orphan drug designation

5. Scale – with over 800 attendees , 190+ speakers , from 30+ countries , this is the largest orphan drugs/rare disease focused conference globally. In 2018 we’re expecting over 1,000 attendees from 40+ countries and over 250 sessions and presentations

6. High-level partnerships – WODC is the only conference officially endorsed and sponsored by key rare disease and research organizations and institutions such as NORD, EURORDIS and NIH-NCATS

7. Patient Advocacy Groups – the conference subsidizes the attendance of over 200 patient groups from US, Europe, Asia and other countries, and covers their evolving role in orphan drug development and commercialization, including successful collaboration case studies with the industry

8. Innovation – Great focus on scientific and technological innovation, with seminars on next generation therapies as well talks throughout the agenda on orphan biosimilars, digital & connected health, gene editing & gene therapies, genetic testing & genomics sequencing, data analytics, bioinformatics

9. Leading solution providers  – being an industry driven conference, WODC focuses on bringing only solution providers with a very innovative or relevant approach to clinical development and manufacturing (CROs, CMOs, CDMOs), regulatory and strategic consulting, data analytics, diagnostics & genetic testing, and other key areas of need. 

10. Venue – held at the Gaylord National Harbor Resort and Convention Center ,strategically located in Washington D.C. for easy access by US and global attendees

 

DOWNLOAD PROSPECTUS

 

INTERESTED IN GETTING INVOLVED?

Contact Andre Singer at andre.singer@terrapinn.com
or  +1 646 619 1797